<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Seo B</submitter><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>European Commission</funding><funding>NIH HHS</funding><pagination>1759-1766</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9761772</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>116(6)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Omega-3 (n-3) and omega-6 (n-6) fatty acids may contribute to oxidative stress and inflammation, which are related to telomere shortening. Evidence supporting an association between intake of n-3 or n-6 fatty acids and leukocyte telomere length (LTL) in males has been limited.&lt;h4>Objectives&lt;/h4>We conducted a cross-sectional study to examine the associations of total or individual n-3 or total n-6 fatty acid intake with LTL in US males.&lt;h4>Methods&lt;/h4>We included 2,494 US males with LTL measurement from 4 nested case-control studies within the Health Professionals Follow-Up Study. Individuals with previous histories of cancers, diabetes, and cardiovascular diseases at or before blood collection were excluded. Blood collection was performed between 1993 and 1995, and relevant information including n-3 and n-6 intake was collected in 1994 by questionnaire. The LTL was log-transformed and Z scores of the LTL were calculated for statistical analyses by standardizing the LTL in comparison with the mean within each selected nested case-control study.&lt;h4>Results&lt;/h4>We found that consumption of DHA (22:6n-3) was positively associated with LTL. In the multivariable-adjusted model, compared with individuals who had the lowest intake of DHA (i.e., first quartile group), the percentage differences (95% CIs) of LTL were -3.7 (-13.7, 7.5), 7.0 (-4.3, 19.7), and 8.2 (-3.5, 21.3) for individuals in the second, third, and fourth quartiles of consumption, respectively (P-trend = 0.0498). We did not find significant associations between total n-3 or total n-6 fatty acid intakes and LTL. In addition, we found that males who consumed canned tuna had longer LTL than those who did not; in the multivariable-adjusted model, the percentage difference of LTL was 10.5 (95% CI: 1.3, 20.4) (P = 0.02).&lt;h4>Conclusions&lt;/h4>Our results suggest that higher intakes of DHA and canned tuna consumption are associated with longer LTL.</pubmed_abstract><journal>The American journal of clinical nutrition</journal><pubmed_title>Association of omega-3 and omega-6 fatty acid intake with leukocyte telomere length in US males.</pubmed_title><pmcid>PMC9761772</pmcid><funding_grant_id>U01 CA167552</funding_grant_id><pubmed_authors>Giovannucci EL</pubmed_authors><pubmed_authors>Chan AT</pubmed_authors><pubmed_authors>Yang K</pubmed_authors><pubmed_authors>Qureshi AA</pubmed_authors><pubmed_authors>Nan H</pubmed_authors><pubmed_authors>Kahe K</pubmed_authors><pubmed_authors>Seo B</pubmed_authors><pubmed_authors>Cho E</pubmed_authors><pubmed_authors>De Vivo I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association of omega-3 and omega-6 fatty acid intake with leukocyte telomere length in US males.</name><description>&lt;h4>Background&lt;/h4>Omega-3 (n-3) and omega-6 (n-6) fatty acids may contribute to oxidative stress and inflammation, which are related to telomere shortening. Evidence supporting an association between intake of n-3 or n-6 fatty acids and leukocyte telomere length (LTL) in males has been limited.&lt;h4>Objectives&lt;/h4>We conducted a cross-sectional study to examine the associations of total or individual n-3 or total n-6 fatty acid intake with LTL in US males.&lt;h4>Methods&lt;/h4>We included 2,494 US males with LTL measurement from 4 nested case-control studies within the Health Professionals Follow-Up Study. Individuals with previous histories of cancers, diabetes, and cardiovascular diseases at or before blood collection were excluded. Blood collection was performed between 1993 and 1995, and relevant information including n-3 and n-6 intake was collected in 1994 by questionnaire. The LTL was log-transformed and Z scores of the LTL were calculated for statistical analyses by standardizing the LTL in comparison with the mean within each selected nested case-control study.&lt;h4>Results&lt;/h4>We found that consumption of DHA (22:6n-3) was positively associated with LTL. In the multivariable-adjusted model, compared with individuals who had the lowest intake of DHA (i.e., first quartile group), the percentage differences (95% CIs) of LTL were -3.7 (-13.7, 7.5), 7.0 (-4.3, 19.7), and 8.2 (-3.5, 21.3) for individuals in the second, third, and fourth quartiles of consumption, respectively (P-trend = 0.0498). We did not find significant associations between total n-3 or total n-6 fatty acid intakes and LTL. In addition, we found that males who consumed canned tuna had longer LTL than those who did not; in the multivariable-adjusted model, the percentage difference of LTL was 10.5 (95% CI: 1.3, 20.4) (P = 0.02).&lt;h4>Conclusions&lt;/h4>Our results suggest that higher intakes of DHA and canned tuna consumption are associated with longer LTL.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2026-06-22T03:16:53.563Z</modification><creation>2025-04-05T10:32:06.512Z</creation></dates><accession>S-EPMC9761772</accession><cross_references><pubmed>36130216</pubmed><doi>10.1093/ajcn/nqac263</doi></cross_references></HashMap>